Harold Davidson & Associates Inc. Bristol Myers Squibb CO Transaction History
Harold Davidson & Associates Inc.
- $154 Billion
- Q2 2025
A detailed history of Harold Davidson & Associates Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Harold Davidson & Associates Inc. holds 7,851 shares of BMY stock, worth $361,695. This represents 0.24% of its overall portfolio holdings.
Number of Shares
7,851
Previous 11,486
31.65%
Holding current value
$361,695
Previous $701 Million
48.12%
% of portfolio
0.24%
Previous 0.38%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.64BCall Options Held
22.5MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.98 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.31 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.98 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.36 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.26 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...